HF
GLSI icon

HRT Financial’s Greenwich LifeSciences GLSI Stock Holding History

HRT Financial’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,165
Closed -$302K – 2520
2024
Q1 		$302K Buy
+15,165
New +$187K ﹤0.01% 1546
2023
Q3 		– Sell
-10,136
Closed -$97K – 2657
2023
Q2 		$97K Sell
10,136
-8,470
-46% -$94.7K ﹤0.01% 1977
2023
Q1 		$256K Buy
+18,606
New +$295K ﹤0.01% 1814
2022
Q4 		– Sell
-12,029
Closed -$109K – 2706
2022
Q3 		$109K Buy
+12,029
New +$111K ﹤0.01% 2374
2022
Q1 		– Sell
-15,971
Closed -$388K – 3370
2021
Q4 		$388K Buy
+15,971
New +$534K ﹤0.01% 2096
2021
Q2 		– Sell
-10,952
Closed -$373K – 3087
2021
Q1 		$373K Buy
+10,952
New +$373K ﹤0.01% 1983

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HRT Financial's GLSI Position: Q2 2024 in Review

HRT Financial sold out of Greenwich LifeSciences (GLSI) in Q2 2024, closing a stake of 15,165 shares — an estimated $302K sold.

HRT Financial first reported a position in GLSI in Q1 2021 and held it in 6 quarters. The position peaked at $388K in Q4 2021. 34 funds tracked by Wall St. Rank hold GLSI as of Q2 2024.

  • HRT Financial reported no remaining Greenwich LifeSciences position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 15,165 Greenwich LifeSciences shares in Q2 2024, an estimated $302K.
  • HRT Financial first reported a position in Greenwich LifeSciences in Q1 2021 and held it in 6 quarters.
  • HRT Financial's Greenwich LifeSciences position peaked at $388K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.